Hepatitis B virus pregenomic RNA in hepatocellular carcinoma:A nosological and prognosticdeterminant
HCC replicating HBV represents a subtype of weakly invasive HCC with a transcriptomic signature.
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
This study investigated the potential to discontinue tenofovir disoproxil fumarate (TDF) therapy in HBeAg-negative patients.
Discontinue TDF Therapy
Fine-Tuning Hepatitis B Treatment Strategies（2）
Gao and colleagues evaluated the effect of antiviral therapy on the incidence of HCC in patients with cirrhosis with lower HBV DNA levels.
HBV DNA Load
Fine-Tuning Hepatitis B Treatment Strategies（1）
Early diagnosis of HBV through effective screening programs allows timely initiation of therapy to prevent disease progression and decompensation.
Chronic Hepatitis B
Systematic review with meta-analysis the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus
The pooled results from comparative trials (599 pregnancies) showed that tenofovir significantly reduced the risk of infant hepatitis B surface antigen seropositivity by 77% .
Medical Management of Severe Alcoholic Hepatitis
Medical management recommendations for severe alcoholic hepatitis
Best Practice Advice
Severe Alcoholic Hepatitis
China Clears First All-Oral Chronic Hepatitis C Regimen
The China Food and Drug Administration (CFDA) has approved the country's first all-oral, interferon-and ribavirin-free direct-acting antiviral regimen for chronic hepatitis C virus (HCV) infection.
Eiger Files New Drug Application for Lambda as Hepatitis D Therapy, Starts Clinical Trials
Unfortunately HDV remains a large unmet medical need because of the lack of any effective therapy for this most aggressive form of viral hepatitis.
FDA Reviewing Application for Opdivo Use in Hepatocellular Carcinoma
The U.S. Food and Drug Administration (FDA) recently accepted a supplemental Biologics License Application (sBLA) to extend the use of Opdivo (nivolumab) to patients with hepatocellular carcinoma (HCC).
Newly Diagnosed Cases of Hepatitis Delta Virus Infection in US is Increasing
HDV causes more severe liver disease than HBV alone, and is linked to accelerated liver fibrosis, liver cancer, and liver failure.
PRC Online Drug Information Service Certificate No.：(M)-Non-operating-2014-0006
Copyright @ Cosunter Co., Ltd. 2006-2016. All rights reserved
M. ICP. B. No. 11026770 Website statistics